As of today, two major causal treatments of AIS are approved: intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) and endovascular treatment (mechanical thrombectomy), both targeting rapid recanalization of the blocked vessel3. Here, PLAT is linked to androgen insensitivity syndrome.